Local view for "http://purl.org/linkedpolitics/eu/plenary/2005-09-27-Speech-2-093"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2005-09-27"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20050927.15.2-093"2
lpv:hasSubsequent	lp_eu:2005-09-27-Speech-2-0942
lpv:speaker	lp:Luís Queiró2
lpv:spokenAs	substitute; Delegation for relations with Mercosur (2004-09-15--2007-03-13)3 member_of_the_bureau; EPP-ED (2004-11-14--2009-07-13)3 member; SEDE (2004-07-21--2007-01-14)3 substitute; AFET (2004-07-21--2007-01-14)3 unknown; Coligaçao Força Portugal (PPD/PSD.CDS-PP) (2004-07-20--2007-11-22)3 vice-chair; TRAN (2004-07-22--2007-01-14)3 member; Delegation for relations with the countries of Central America (2004-09-15--2007-03-13)3
lpv:translated text	". The Florenz report on fees payable to the European Medicines Agency is a good example of the way in which we should take on board the experience and the evaluations carried out by the Community’s agencies. The report before us follows a significant change in the powers of this Agency, which have not merely been changed but have in fact been extended. It is therefore of vital importance that this Agency be given a solid and up-to-date financial framework. The purpose of the amendments that were tabled was to clarify the principle of setting the fees payable to the Agency and reducing rates for traditional herbal medicinal products. Accordingly, the rapporteur’s position is that the level of the fee should be commensurate with the actual workload involved in evaluating the products. I therefore voted in favour of the Florenz report on fees payable to the European Medicines Agency."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph